Last modified: August 18, 2021
Beginning July 1, 2021, UnitedHealthcare commercial members in the Neonatal Intensive Care Unit (NICU) who were born at 32 weeks’ gestation or older, and where a genetic condition is suspected, are eligible for select rapid tests through a new genetics program.
Having this information for NICU patients is especially important, as up to 30% of babies in the NICU setting have an underlying genetic condition.
Receiving a genetic diagnosis while in the NICU may provide you with additional information to help you create a personalized care plan, which may include targeted therapies, procedures or redirection of care.
If you are a provider in this setting, you may continue to utilize your current genetic test ordering process through your laboratory of choice, or you may choose to utilize one of the program’s participating lab tests. When utilizing a test that is part of the new program, please refer to the program guidelines outlined in the FAQ below to help ensure proper reimbursement.
The FAQ and clinical checklist includes details and resources about the following: